Drug · DIN 02453754
PRALUENT
SINGLE-USE PREFILLED SYRINGE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 4, 2021; first marketed August 13, 2016.
- Drug Identification Number (DIN)
- 02453754
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Alirocumab C10AX14
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALIROCUMAB | 75 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 11, 2016: NOC 17976New Drug Submission (NDS)
Other DINs named PRALUENT
- DIN 02453819 · Marketed
- DIN 02453835 · Marketed
- DIN 02547732 · Marketed
- DIN 02453762 · Cancelled Post Market